Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118487) titled 'Evaluation of the Safety and Immunogenicity of the Recombinant Herpes Zoster Vaccine (CHO Cell) in Individuals Aged 40 Years and Above: A Phase I Clinical Tria' on Feb. 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hubei Provincial Center for Disease Control and Prevention
Condition:
Varicella-Zoster
Intervention:
Investigational Vaccine:to receive the experimental vaccine
Positive Control Vaccine:to receive the positive control vaccine
Negative Control:to be administered the negative control (normal saline)
Recruitment Status: Recruiting
Phase: 1
Date of First Enrollment...